HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between insulin-like growth factor 1, leptin and ghrelin levels and catch-up growth in small for gestational age infants of 27-31 weeks during neonatal intensive care unit admission.

AbstractAIM:
Poor post-natal growth is related to later morbidity and poor cognitive development in preterm infants. We investigated the relationship between plasma insulin-like growth factor 1 (IGF-1), leptin, active ghrelin levels and post-natal growth in preterm infants small for gestational age (SGA).
METHODS:
Plasma IGF-1, leptin and active ghrelin levels were measured at birth and at 2, 4, 6 and 8 weeks after birth in 42 very low birthweight (VLBW) infants (born between 27 and 31 weeks of gestation), including 14 SGA infants with extrauterine growth restriction (EUGR), 6 SGA infants without EUGR and 22 appropriate-for-gestational-age infants.
RESULTS:
At birth, IGF-1 levels in SGA infants without EUGR did not differ significantly from those in SGA infants with EUGR. However, IGF-1 levels in SGA infants without EUGR were as high as those observed in appropriate-for-gestational-age infants and were significantly different from those in SGA infants with EUGR at 4 and 8 weeks of age. Leptin and ghrelin levels did not differ significantly among the three groups at any time point.
CONCLUSION:
IGF-1 is related to catch-up growth in SGA VLBW infants during neonatal intensive care unit admission; however, this does not appear to be the case for leptin and ghrelin. IGF-1 level monitoring may be useful for predicting EUGR in preterm VLBW infants.
AuthorsNatsuki Ohkawa, Hiromichi Shoji, Naho Ikeda, Hiroki Suganuma, Toshiaki Shimizu
JournalJournal of paediatrics and child health (J Paediatr Child Health) Vol. 53 Issue 1 Pg. 62-67 (Jan 2017) ISSN: 1440-1754 [Electronic] Australia
PMID27565941 (Publication Type: Journal Article)
Copyright© 2016 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Chemical References
  • Ghrelin
  • Leptin
  • Insulin-Like Growth Factor I
Topics
  • Child Development (drug effects)
  • Female
  • Gestational Age
  • Ghrelin (blood)
  • Humans
  • Infant, Newborn
  • Infant, Small for Gestational Age (growth & development)
  • Infant, Very Low Birth Weight
  • Insulin-Like Growth Factor I (administration & dosage)
  • Intensive Care Units, Neonatal
  • Leptin (blood)
  • Male
  • Pilot Projects
  • Tokyo

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: